The rivastigmine patch, a dementia medicine, can cause nausea, vomiting, diarrhea, appetite loss, weight loss, and skin irritation. Caregivers should also watch for dehydration, fainting, severe skin reactions, bleeding signs, seizures, urinary problems, and accidental double-patching. The patch is indicated for mild through severe Alzheimer's dementia and mild-to-moderate Parkinson's disease dementia, according to National Library of Medicine DailyMed labeling. Tracking symptoms and patch use can help caregivers recognize problems that need clinical attention.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Digestive symptoms and weight loss
- When is a skin reaction concerning?
- Preventing accidental double-patching
- Heart concerns and other warning signs
- Restarting after a treatment break
Digestive symptoms and weight loss
Nausea, vomiting, diarrhea, appetite loss, and weight loss are dose-related effects. Prolonged vomiting or diarrhea can lead to dehydration and serious complications.
In one 24-week Alzheimer's trial, nausea affected 7% of patients using the 9.5-mg/24-hour patch, compared with 5% receiving placebo. Vomiting occurred in 6% versus 3%, and diarrhea in 6% versus 3%, according to the DailyMed trial results. Caregivers can monitor: Contact the prescriber when vomiting or diarrhea persists, fluid intake falls, or weight loss becomes noticeable.
- Episodes of vomiting or diarrhea
- How much the person eats and drinks
- Appetite changes
- Weight changes
- Whether digestive symptoms continue or worsen
When is a skin reaction concerning?
Redness, itching, irritation, or a rash under the patch can occur. A small, mild reaction does not automatically mean the person has a serious allergy.
Application-site reactions caused no more than 2.3% of patch-treated patients to discontinue treatment and were usually slight or mild. However, DailyMed safety guidance says to remove the patch and seek clinical direction if the reaction: Note the reaction's size and appearance so the prescriber receives a clear description.
- Spreads beyond the patch area
- Becomes more intense
- Develops blisters
- Does not improve within 48 hours
Preventing accidental double-patching
Only one rivastigmine patch should be worn at a time. Accidentally leaving an old patch in place before applying another has caused serious reactions, hospitalization, and, rarely, death. A simple application check can reduce this risk: If more than one patch may have been worn, seek urgent clinical guidance rather than waiting for symptoms.
- Find and remove the old patch before opening a new one.
- Confirm visually that only one patch remains on the body.
- Record when the new patch was applied.
- Include patch status during caregiver shift changes.
Heart concerns and other warning signs
Rivastigmine may slow the heart rate, especially in someone with cardiac conduction disease, which affects the heart's electrical signaling. Beta-blockers can add to the risk of a slow heart rate and fainting.
Keep the prescriber informed about the complete medication list, including beta-blockers. Report fainting episodes promptly so medication and heart-related risks can be reviewed. The National Library of Medicine's MedlinePlus guidance also identifies several symptoms that require prompt reporting:.
- Black or tarry stools
- Blood in the stool or vomit
- A seizure
- Painful or difficult urination
Restarting after a treatment break
Do not simply restart the previous patch strength after an intolerance-related break lasting longer than three days. DailyMed labeling directs patients to restart at 4.6 mg/24 hours and increase the dose again under clinical direction, reducing the risk of severe vomiting.
Contact the prescriber before restarting. A caregiver handoff should clearly record when the last patch was removed and why treatment stopped.
